National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

mitosis-angiogenesis inhibitor R1530
A pyrazolobenzodiazepine small molecule with potential antiangiogenesis and antineoplastic activities. Mitosis-angiogenesis inhibitor (MAI) R1530 inhibits multiple receptor tyrosine kinases involved in angiogenesis, such as vascular endothelial growth factor receptor (VEGFR)-1, -2, -3, platelet-derived growth factor receptor (PDGFR) beta‚ FMS-like tyrosine kinase (Flt)-3, and fibroblast growth factor receptor (FGFR) -1, -2. In addition, this agents exhibits anti-proliferative activity by initiating mitotic arrest and inducing apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:MAI R1530
Code name:R1530

Previous:Mithracin, mitoguazone, mitolactol, mitomycin C, Mitosan
Next:mitotane, mitoxantrone hydrochloride, Mitozytrex, mivobulin isethionate, mixed bacteria vaccine